Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis.

We are particularly interested in studies that integrate engineering breakthroughs with clinical practice to address complex neurological conditions such as: · Alzheimer’s Disease · Amyotrophic ...

Dallas steakhouse owner Al Biernat, whose charismatic presence at his namesake restaurant attracted both the famous and the ...

After his ALS diagnosis, Zac Brown Band's John Driskell Hopkins plans to donate $3 million to fund research through his "Hop ...

Grammy winner John Driskell Hopkins, known as "Hop" from the Zac Brown Band, is turning his personal battle with amyotrophic ...

John Rzeznik, Brian Fallon, Pete Steinkopf, Dramarama, Willie Nile, Joe Grushecky and the Houserockers and more set for Bob's ...

In October, Clene presented the design for RESTORE-ALS, its potentially confirmatory international Phase 3 clinical trial of CNMAu8 30 mg, at the 2024 Annual Northeast Amyotrophic Lateral Sclerosis ...

Researchers from the University of California – San Diego (CA, USA) have worked backwards, identifying the pathway leading to ...

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

NEW YORK – Trace Neuroscience launched on Tuesday, having raised $101 million in a Series A financing round and with a lead therapeutic development program exploring an RNA-based treatment approach ...

A fundraiser has been launched for Will Vess, a 57-year-old retired United States Air Force veteran who was recently ...

Ten years after her sexual assault, she discovered that the evidence in her rape kit hadn’t been tested — and neither had ...